Gene · 5962
Papers3,092
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,092
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Contribution of radixin and ezrin to the maintenance of hepatocytes' excretory function in health and disease. | Heliyon | 2023 | 37928027 | PubTator, text mining | PubMed |
| Downregulation of complement factor H attenuates the stemness of MDA‑MB‑231 breast cancer cells via modulation of the ERK and p38 signaling pathways. | Oncol Lett | 2023 | 37927420 | PubTator, text mining | PubMed |
| Kinome profiling identifies MARK3 and STK10 as potential therapeutic targets in uveal melanoma. | J Biol Chem | 2023 | 37923138 | PubTator, text mining | PubMed |
| Targeting CD44 Receptor Pathways in Degenerative Joint Diseases: Involvement of Proteoglycan-4 (PRG4). | Pharmaceuticals (Basel) | 2023 | 37895896 | PubTator, text mining | PubMed |
| CD44 Intracellular Domain: A Long Tale of a Short Tail. | Cancers (Basel) | 2023 | 37894408 | PubTator, text mining | PubMed |
| Tunneling Nanotube: An Enticing Cell-Cell Communication in the Nervous System. | Biology (Basel) | 2023 | 37886998 | PubTator, text mining | PubMed |
| Discovery of FERM domain protein-protein interaction inhibitors for MSN and CD44 as a potential therapeutic approach for Alzheimer's disease. | J Biol Chem | 2023 | 37866628 | PubTator, text mining | PubMed |
| Proteome profiling of early gestational plasma reveals novel biomarkers of congenital heart disease. | EMBO Mol Med | 2023 | 37840432 | PubTator, text mining | PubMed |
| miR-199a and miR-199b facilitate diffuse gastric cancer progression by targeting Frizzled-6. | Sci Rep | 2023 | 37838767 | PubTator, text mining | PubMed |
| Rho-Kinase Inhibitors as Emerging Targets for Glaucoma Therapy. | Ophthalmol Ther | 2023 | 37837578 | PubTator, text mining | PubMed |
| PIP5Kγ Mediates PI(4,5)P2/Merlin/LATS1 Signaling Activation and Interplays with Hsc70 in Hippo-YAP Pathway Regulation. | Int J Mol Sci | 2023 | 37834234 | PubTator, text mining | PubMed |
| Structural Analysis of Janus Tyrosine Kinase Variants in Hematological Malignancies: Implications for Drug Development and Opportunities for Novel Therapeutic Strategies. | Int J Mol Sci | 2023 | 37834019 | PubTator, text mining | PubMed |
| Plasmodium falciparum exploits CD44 as a coreceptor for erythrocyte invasion. | Blood | 2023 | 37832027 | PubTator, text mining | PubMed |
| Universal method for the isolation of microvessels from frozen brain tissue: A proof-of-concept multiomic investigation of the neurovasculature. | Brain Behav Immun Health | 2023 | 37822873 | PubTator, text mining | PubMed |
| [Clinical significance and pathogenesis analysis of Moesin in multiple myeloma]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 37803842 | PubTator, text mining | PubMed |
| Endothelial deletion of EPH receptor A4 alters single-cell profile and Tie2/Akap12 signaling to preserve blood-brain barrier integrity. | Proc Natl Acad Sci U S A | 2023 | 37796990 | PubTator, text mining | PubMed |
| Ezrin promotes esophageal squamous cell carcinoma progression via the Hippo signaling pathway. | Open Life Sci | 2023 | 37791063 | PubTator, text mining | PubMed |
| Synthesis and Characterization of Azido- and Nitratoalkyl Nitropyrazoles as Potential Melt-Cast Explosives. | Molecules | 2023 | 37764265 | PubTator, text mining | PubMed |
| MicroRNAs Can Influence Ovarian Cancer Progression by Dysregulating Integrin Activity. | Cancers (Basel) | 2023 | 37760437 | PubTator, text mining | PubMed |
| Effects of Nitro-Oxidative Stress on Biomolecules: Part 1-Non-Reactive Molecular Dynamics Simulations. | Biomolecules | 2023 | 37759771 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5962/papers?page=7